EN
About
ABOUT US
About Us
Shenzhen CAS-Envision Medical Technology Co., Ltd.is a high-tech start-up enterprise held by SIAT (Shenzhen Institutes of Advanced Technology,Chinese Academy of Sciences). Relying on first-class talents introduced from overseas, it established “artificial retina” Guangdong innovation team and Shenzhen peacock team and industrialized their technical achievements. In 2016, the team won the national champion team of biomedical industry in the China Innovation and Entrepreneurship Competition, the highest standard innovation competition in China. The preliminary R & D has received a huge subsidy of nearly 100 million yuan from government and CAS. The company present main goal is to develop high-resolution artificial retina products and derivative technologies which are international leading and domestic pioneering. The company has formed a close strategic cooperation with SIAT and it is capable of carrying out high-level R & D on a series of high-configuration platforms. It established a joint laboratory with CAS to jointly train high-end R&D talents. It has R & D conditions and innovation culture in line with international standards. The company's vision is to become the leader and...
More...
Development process
2013
2014
2015
2016
2017
2018
2019
2020
  • In 2013, the peacock team and Guangzhou innovation team were approved and the micro nano center was established.
  • In 2014, project kick-off meeting was held, large scale laboratory was built.
  • In 2015, ultra clean room of 1000/100 level micro nano processing is completed.
  • In 2016, won the national champion team of biomedical industry in China Innovation and Entrepreneurship Competition.
  • In 2017, the prototype was finalized, and the shareholders agreed to establish the company, which was introduced as a major project in Longgang district.
  • In 2018, the company was established, the joint laboratory was opened, and the clean factory passed the acceptance.
  • In 2019, carry out industrial R & D and production in an all-round way.
  • In 2020, let's stay tuned.
Company Culture
Mission:Create cutting-edge medical and health products with future science and technology at right time and right place with right people.
Vision:Become a platform leading enterprise in human body implanted medical electronics and lead the new future of human evolution.
Quality policy:Safety is above everything, quality brings brightness, and innovation wins the future.
Honor
Finalist of The Fifth China Innovation and Entrepreneurship Competition.
Third place in biology and life technology industry.
Team no.1 in the 2016 Entrepreneurship and Innovation Competition.
Excellent team of the 2016 Shenzhen Innovation Competition.
Team second prize in biological team of the 2016 Entrepreneurship and Innovation Competition.
Team second prize in the 2016 Final Competition of Entrepreneurship and Innovation.
The second prize in the 2017 National AI Elite Challenge for Blind People's Glasses.
2017 Excellent Product Award--cell freezing system.
2018 Excellent Product Award--artificial retinas.
Award of excellence in the 2019 Entrepreneurship and Innovation Competition.
Promotion certificate of the semi-final of the 2019 Entrepreneurship and Innovation Competition.
Industry excellence award of the 2019 Entrepreneurship and Innovation Competition.
注册证
商标注册证
商标注册证
商标注册证
商标注册证
About Us

Shenzhen CAS-Envision Medical Technology Co., Ltd.is a high-tech start-up enterprise held by SIAT (Shenzhen Institutes of Advanced Technology,Chinese Academy of Sciences). Relying on first-class talents introduced from overseas, it established “artificial retina” Guangdong innovation team and Shenzhen peacock team and industrialized their technical achievements.


In 2016, the team won the national champion team of biomedical industry in the China Innovation and Entrepreneurship Competition, the highest standard innovation competition in China. The preliminary R & D has received a huge subsidy of nearly 100 million yuan from government and CAS. The company present main goal is to develop high-resolution artificial retina products and derivative technologies which are international leading and domestic pioneering. The company has formed a close strategic cooperation with SIAT and it is capable of carrying out high-level R & D on a series of high-configuration platforms. It established a joint laboratory with CAS to jointly train high-end R&D talents. It has R & D conditions and innovation culture in line with international standards.


The company's vision is to become the leader and pioneer of brain-computer interface, neural regulation and other future emerging industries, it is committed to developing long-term implanted medical microsystem, providing advanced high-density neural prosthesis and core technology solutions, and applying cutting-edge technology to visual rehabilitation and assistance for the majority of the visually impaired .